MedPath
NMPA Approval

Lenvatinib Mesilate Capsules

国药准字H20213946

December 14, 2021

Drug Information

甲磺酸仑伐替尼胶囊

胶囊剂

4mg(按C21H19ClN4O4计)

化学药品

December 14, 2021

Company Information

Applicant Company

岳阳县城关镇荣新路(县生态工业园3号)

Manufacturing Company

湖南省岳阳经济技术开发区康王工业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸仑伐替尼胶囊 - NMPA 批准文号 | MedPath